Compare Stryker Corporation (SYK) vs Vir Biotechnology Inc. Common Stock (VIR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Stryker Corporation vs Vir Biotechnology Inc. Common Stock — how do they compare? Stryker Corporation trades at $283.6 (market cap $108.02B), while Vir Biotechnology Inc. Common Stock trades at $10.2 (market cap $1.76B). The key difference: Stryker Corporation is far larger — about 61.4× Vir Biotechnology Inc. Common Stock's market cap, and Stryker Corporation pays a 1.25% dividend while Vir Biotechnology Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Stryker Corporation for 22 Days and Vir Biotechnology Inc. Common Stock for 0 Days on average.
| SYK | VIR | |
|---|---|---|
Market Cap | $108.02B | $1.76B |
Volume | 2,222,698 | 2,764,948 |
Sector | Health | Health |
52-Week High | $388.35 | $11.78 |
52-Week Low | $269.75 | $5.12 |
Typical Hold Time | 22 Days | 0 Days |
Enterprise Value | $119.49B | $1.32B |
Dividend Yield | 1.25% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Stryker (SYK) trades at $282.63, showing minimal daily change. The stock exhibits neutral technical signals with mixed moving averages and oscillators. Fundamentally, the company maintains strong profitability with a 14.43% net income margin and 16.51% ROE. Recent Q2 2026 earnings beat expectations, though Q1 2026 was a miss. Analyst sentiment is strongly bullish with a $365.89 consensus price target, but recent news highlights legal investigations and a manufacturing issue disclosure that caused an 8.8% share drop in early September 2026.
The outlook for SYK is cautiously optimistic. Strong fundamentals and analyst support suggest upside potential, but near-term risks from legal scrutiny and operational challenges could pressure the stock. Investors should weigh robust financial health against headline volatility ahead of Q3 2026 earnings on October 29, 2026.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Stryker Corporation
Stryker is a global leader in medical technology, specializing in Orthopaedics, MedSurg, and Neurotechnology. It is renowned for its highly decentralized business model, which empowers 22 specialized business units to drive innovation and category leadership. With its market-leading Mako SmartRobotics™ platform and a relentless M&A strategy, Stryker provides a comprehensive ecosystem of connected surgical tools, implants, and digital solutions that improve both clinical and financial outcomes for hospitals worldwide.
Read more on SYK →About Vir Biotechnology Inc. Common Stock
Vir Biotechnology, Inc. is a US clinical-stage biopharmaceutical company that develops monoclonal antibody-based medicines to treat and prevent serious infectious diseases.
Read more on VIR →
